Neonatal nonketotic hyperglycinemia, attenuated phenotype

Keywords: Hyperglycinemia; Nonketotic, Glycine, Newborn, Epilepsy, Hiccups

Abstract

Introduction. Nonketotic hyperglycinemia (NKH) is an autosomal recessive innate error of metabolism, whose main characteristic is the accumulation of glycine in body fluids, produced by a failure in the enzymatic cleavage complex of this amino acid. Case Presentation. We present the case of a 36-week-old newborn, with spontaneous neonatal adaptation, no history of perinatal noxa or documented hypoglycemia, who after a short period of 24 hours presented progressive neurological deterioration, rapid alteration of consciousness to coma and ventilatory failure. At admission the patient was noted for severe generalized hypotonia, hyporeflexia, absence of primitive reflexes, with episodes of isolated hiccups and abnormal eye movements. In view of the suspicion of an innate error of metabolism, an amino acid profile was performed, showing a significant elevation of glycine, 1417 umol/L (reference 94-553 umol/L). Amino acids were requested in cerebrospinal fluid, glycine very elevated 1263 umol/L (reference 3-7 umol/L), confirming the suspicion of nonketotic hyperglycinemia. It was decided to start treatment with sodium benzoate and dextromethorphan. The initial MRI was normal; in the control study, findings previously reported in the literature for this pathology were found, as well as in the electroencephalogram. Discussion. Most children with NKH will display it in the neonatal period or early infancy, with only the mildest cases presenting in late infancy or childhood. In neonatal-onset cases, 85% have severe NKH and 15% have attenuated form, as in this case. The diagnosis of NKH is made based on clinical suspicion, confirmed by laboratory findings, with the characteristic alteration of glycine in both plasma and CSF and supported by neuroimaging and electroencephalogram (EEG) findings. Conclusions. NKH is not such an unusual condition, although it is possibly underdiagnosed because of its catastrophic presentation and because it does not produce major metabolic disorders that are quickly diagnosed. For this reason, in a patient with a suggestive clinical condition, with coma, respiratory alteration and unmanageable seizures, and very characteristically hiccups, the study of amino acids in plasma, neuroimaging and EEG should be requested, in order to establish early treatment.




References

Uribe A. Hiperglicinemia no cetósica, un aminoacidopatía frecuente en Colombia. Semilleros med 2016;10(1):103-107. Disponible en: https://www.researchgate.net/publication/313309765_Hiperglicinemia_No_Cetosica_un_aminoacidopatia_frecuente_en_Colombia

Iqbal M, Prasad M, Mordekar S. Nonketotic hyperglycinemia case series. J Pediatr Neurosci [Internet] 2015;10(4):355. https://doi.org/10.4103/1817-1745.174445

Poothrikovil RP, Al Thihli K, Al Futaisi A, Al Murshidi F. Nonketotic Hyperglycinemia: Two Case Reports and Review. Neurodiagn J [Internet] 2019 Jul 3;59(3):142-151. https://doi.org/10.1080/21646821.2019.1645549

Cifuentes Y, Bermudez M, Arteaga C. Encefalopatía neonatal. Algo más que asfixia al nacer. Rev la Fac Med [Internet] 2007;55(2):126-134. Disponible en: https://revistas.unal.edu.co/index.php/revfacmed/article/view/22059/63881

Trujillo J, Tobón S, Ortiz B, Mesa S, Vélez G, Cornejo J. Caracterización clínica, bioquímica e imagenológica en una cohorte de pacientes diagnosticados con hiperglicinemia no cetósica clásica: estudio ambispectivo 2000-2014, Medellín, Colombia. Acta neurol colomb 2014;31(4):378-384. https://doi.org/10.22379/2422402255

Swanson MA, Coughlin CR, Scharer GH, Szerlong HJ, Bjoraker KJ, Spector EB, et al. Biochemical and molecular predictors for prognosis in nonketotic hyperglycinemia. Ann Neurol [Internet] 2015 Oct;78(4):606-618. Disponible en: http://doi.wiley.com/10.1002/ana.24485

Van Hove JLK, Coughlin C II, Swanson M, Hennermann JB. Nonketotic Hyperglycinemia. 2002 Nov 14 [updated 2019 May 23]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mirzaa G, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2021. PMID: 20301531. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK1357/

Hoover-Fong JE, Shah S, Van Hove JLK, Applegarth D, Toone J, Hamosh A. Natural history of nonketotic hyperglycinemia in 65 patients. Neurology [Internet]. 2004 Nov 23;63(10):1847-1853. https://doi.org/10.1212/01.WNL.0000144270.83080.29

Applegarth DA, Toone JR. Nonketotic Hyperglycinemia (Glycine Encephalopathy): Laboratory Diagnosis. Mol Genet Metab [Internet]. 2001 Sep;74(1,2):139-146. https://doi.org/10.1006/mgme.2001.3224

Butler CJ, Likeman M, Mallick AA. Distinctive Magnetic Resonance Imaging Findings in Neonatal Nonketotic Hyperglycinemia. Pediatr Neurol 12. [Internet]. 2017 Jul;72(1):90-91. https://doi.org/10.1016/j.pediatrneurol.2017.03.013

Stence NV, Fenton LZ, Levek C, Tong S, Coughlin CR, Hennermann JB, et al. Brain imaging in classic nonketotic hyperglycinemia: Quantitative analysis and relation to phenotype. J Inherit Metab Dis [Internet]. 2019 Mar 20;4(3):438-450. Disponible en: https://onlinelibrary.wiley.com/doi/abs/10.1002/jimd.12072

Bjoraker KJ, Swanson MA, Coughlin CR, Christodoulou J, Tan ES, Fergeson M, et al. Neurodevelopmental Outcome and Treatment Efficacy of Benzoate and Dextromethorphan in Siblings with Attenuated Nonketotic Hyperglycinemia. J Pediatr [Internet] 2016 Mar;170(1):234-239. https://doi.org/10.1016/j.jpeds.2015.12.027

How to Cite
1.
Dellán-Quijada AJ, Useche-Sabogal LA, Espitia-Segura OM, Penagos-Vargas N. Neonatal nonketotic hyperglycinemia, attenuated phenotype. MedUNAB [Internet]. 2021 Aug. 20 [cited 2026 Mar. 9];24(2):268-75. Available from: https://revistasunabeduco.biteca.online/index.php/medunab/article/view/3908

Downloads

Download data is not yet available.
Published
2021-08-20

Altmetric

Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views
Escanea para compartir
QR Code

Some similar items: